GSK
◆ Investment Thesis
Invests in bioelectronic startups working on neuromodulation, wearables, implanted devices and other technology.
◆ About GSK
Action Potential Venture Capital (APVC) is a medical technology venture capital firm founded by GSK in 2013 that invests in **bioelectronic medicines**—treatments using electrical pulses instead of drugs—and their enabling technologies. The firm takes a hands-on approach, serving on the boards of portfolio companies advancing neuromodulation, wearables, implanted devices, and related technologies.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does GSK invest in?
GSK invests in Medtech, Digital Health, IoT & Edge and Sensors & Instrumentation at the growth and seed stages.
Which geographies does GSK focus on?
GSK focuses on United States, and is headquartered in United States.